Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
May 6, 2013
Company News
Novartis pharmaceuticals news
Read More
BioCentury
|
Feb 22, 2010
Clinical News
Lotrel amlodipine/benazepril: Additional Phase III data
Read More
BioCentury
|
Apr 6, 2009
Clinical News
Arverapamil: Completed Phase III enrollment
Read More
BioCentury
|
Jan 26, 2009
Clinical News
Rezular arverapamil: Completed Phase III enrollment
Read More
BioCentury
|
Aug 4, 2008
Clinical News
Exforge: Phase IV data
Read More
BioCentury
|
Jul 21, 2008
Clinical News
Cleviprex clevidipine: Phase III data
Read More
BioCentury
|
May 19, 2008
Product Development
Now it's head-to-head
Read More
BioCentury
|
Apr 7, 2008
Clinical News
Lotrel amlodipine/benazepril: Interim Phase III data
Read More
BioCentury
|
Feb 25, 2008
Clinical News
Rezular averapamil gastrointestinal data
Read More
BioCentury
|
Jan 31, 2008
Distillery Therapeutics
This Week in Therapeutics
Read More
Items per page:
10
1 - 10 of 39